[Enzymatic resistance to imipenem in gram-negative bacilli: NMC-A, an original carbapenemase]
- PMID: 9872010
[Enzymatic resistance to imipenem in gram-negative bacilli: NMC-A, an original carbapenemase]
Abstract
Carbapenems such as imipenem are beta-lactam antibiotics usually stable to the hydrolytic activity of beta-lactamases. Nevertheless, resistance to imipenem by production of carbapenemases has been described in few species of Gram negative bacilli. This mechanism of resistance remains exceptional in Enterobacteriaceae. These carbapenemases are principally metallo-enzymes that possess a zinc ion in their active site. Enterobacter cloacae strain NOR-1, is resistant to imipenem by production of an inducible chromosomal beta-lactamase which is not a metallo-enzyme but an Ambler class A beta-lactamase. This enzyme displays a strong hydrolytic activity against carbapenems but also against cephamycins which has never been previously observed for beta-lactamases of this class. These properties suggest that NMC-A possesses an original tridimensional structure of its active site allowing hydrolysis of molecules generally protected by the configuration of their lateral chain. Crystallographic study of this enzyme will permit to understand its mechanism of action and serve the development of new beta-lactams stable to b-lactamase hydrolytic activity.
Similar articles
-
[Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].Acta Med Croatica. 2004;58(4):307-12. Acta Med Croatica. 2004. PMID: 15700687 Croatian.
-
Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases.Antimicrob Agents Chemother. 2001 Oct;45(10):2831-7. doi: 10.1128/AAC.45.10.2831-2837.2001. Antimicrob Agents Chemother. 2001. PMID: 11557477 Free PMC article.
-
A kinetic study of NMC-A beta-lactamase, an Ambler class A carbapenemase also hydrolyzing cephamycins.FEMS Microbiol Lett. 1996 Sep 15;143(1):29-33. doi: 10.1111/j.1574-6968.1996.tb08457.x. FEMS Microbiol Lett. 1996. PMID: 8807798
-
[Development of Beta-lactamase resistance in enterobacteria].Klin Mikrobiol Infekc Lek. 2006 Jun;12(3):103-7. Klin Mikrobiol Infekc Lek. 2006. PMID: 17051471 Review. Slovak.
-
The impact of carbapenemases on antimicrobial development and therapy.Curr Opin Investig Drugs. 2002 Feb;3(2):218-24. Curr Opin Investig Drugs. 2002. PMID: 12020049 Review.